Thus, the aim of this study is to evaluate the diagnostic value of measuring the automated hematological parameter, Ret-Hb, in chronic hemodialysis patients, compare it with conventional biochemical markers of iron metabolism (e.g., serum ferritin and transferrin saturation), and assess its performance in diagnosing iron deficiency. The gene discussed is GSTM1; the disease is nutritional disorder.